South Korea · Delayed Price · Currency is KRW BCWORLD PHARM. Statistics
Total Valuation
BCWORLD PHARM. has a market cap or net worth of KRW 30.87 billion. The enterprise value is 103.71 billion.
| Market Cap | 30.87B |
| Enterprise Value | 103.71B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
BCWORLD PHARM. has 10.22 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 10.22M |
| Shares Outstanding | 10.22M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | -1.05% |
| Owned by Insiders (%) | 42.37% |
| Owned by Institutions (%) | n/a |
| Float | 5.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.51 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.29 |
| EV / EBITDA | 9.41 |
| EV / EBIT | 36.78 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.53 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 6.89 |
| Debt / FCF | -131.51 |
| Interest Coverage | 0.68 |
Financial Efficiency
Return on equity (ROE) is -1.75% and return on invested capital (ROIC) is 1.90%.
| Return on Equity (ROE) | -1.75% |
| Return on Assets (ROA) | 1.01% |
| Return on Invested Capital (ROIC) | 1.90% |
| Return on Capital Employed (ROCE) | 3.44% |
| Weighted Average Cost of Capital (WACC) | 5.43% |
| Revenue Per Employee | 286.89M |
| Profits Per Employee | -10.35M |
| Employee Count | 280 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.33 |
Taxes
In the past 12 months, BCWORLD PHARM. has paid 486.51 million in taxes.
| Income Tax | 486.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.21% in the last 52 weeks. The beta is 0.72, so BCWORLD PHARM.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -24.21% |
| 50-Day Moving Average | 3,128.00 |
| 200-Day Moving Average | 4,226.80 |
| Relative Strength Index (RSI) | 40.00 |
| Average Volume (20 Days) | 11,340 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BCWORLD PHARM. had revenue of KRW 80.33 billion and -2.90 billion in losses. Loss per share was -311.00.
| Revenue | 80.33B |
| Gross Profit | 30.48B |
| Operating Income | 2.82B |
| Pretax Income | -777.48M |
| Net Income | -2.90B |
| EBITDA | 11.03B |
| EBIT | 2.82B |
| Loss Per Share | -311.00 |
Balance Sheet
The company has 4.94 billion in cash and 75.98 billion in debt, with a net cash position of -71.03 billion or -6,950.05 per share.
| Cash & Cash Equivalents | 4.94B |
| Total Debt | 75.98B |
| Net Cash | -71.03B |
| Net Cash Per Share | -6,950.05 |
| Equity (Book Value) | 71.34B |
| Book Value Per Share | 6,806.16 |
| Working Capital | -43.41B |
Cash Flow
In the last 12 months, operating cash flow was 4.74 billion and capital expenditures -5.32 billion, giving a free cash flow of -577.72 million.
| Operating Cash Flow | 4.74B |
| Capital Expenditures | -5.32B |
| Depreciation & Amortization | 8.21B |
| Net Borrowing | -484.71M |
| Free Cash Flow | -577.72M |
| FCF Per Share | -56.52 |
Margins
Gross margin is 37.94%, with operating and profit margins of 3.51% and -3.61%.
| Gross Margin | 37.94% |
| Operating Margin | 3.51% |
| Pretax Margin | -0.97% |
| Profit Margin | -3.61% |
| EBITDA Margin | 13.73% |
| EBIT Margin | 3.51% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 90.91, which amounts to a dividend yield of 2.99%.
| Dividend Per Share | 90.91 |
| Dividend Yield | 2.99% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | 2.54% |
| Earnings Yield | -9.39% |
| FCF Yield | -1.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2025. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 29, 2025 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
BCWORLD PHARM. has an Altman Z-Score of 0.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.74 |
| Piotroski F-Score | 5 |